D7911
Decylubiquinone
≥97% (HPLC)
Synonym(s):
2,3-Dimethoxy-5-methyl-6-decyl-1,4-benzoquinone
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 mg | Check Cart for Availability | $180.00 | |
| 25 mg | Check Cart for Availability | $364.00 | |
| 100 mg | Please contact Customer Service for Availability | $1,210.00 |
About This Item
Empirical Formula (Hill Notation):
C19H30O4
CAS Number:
Molecular Weight:
322.44
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12162212
MDL number:
Quality Level
assay
≥97% (HPLC)
form
liquid
storage temp.
−20°C
SMILES string
CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(OC)C1=O
InChI
1S/C19H30O4/c1-5-6-7-8-9-10-11-12-13-15-14(2)16(20)18(22-3)19(23-4)17(15)21/h5-13H2,1-4H3
InChI key
VMEGFMNVSYVVOM-UHFFFAOYSA-N
General description
Mitochondrial permeability transition pore (MPTP) inhibitor.
Ubiquinone analog.
Application
- Lysosomal Ca(2+) as a mediator of palmitate-induced lipotoxicity.: This study explores the role of decylubiquinone in modulating lysosomal Ca(2+) levels, providing insights into mechanisms of lipotoxicity and potential therapeutic applications in metabolic diseases (Oh et al., 2023).
- Quinone binding site in a type VI sulfide:quinone oxidoreductase.: This paper investigates the binding dynamics of decylubiquinone in sulfide:quinone oxidoreductase, shedding light on its role in microbial respiration and potential biotechnological applications (Miklovics et al., 2022).
- Protective role of Decylubiquinone against secondary melanoma at lung in B16F10 induced mice.: The study demonstrates the anti-metastatic properties of decylubiquinone in a melanoma mouse model, highlighting its potential as a therapeutic agent in cancer treatment (Chatterjee et al., 2023).
- Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2.: This research identifies decylubiquinone as an inhibitor of colorectal cancer growth by modulating Sirtuin2 expression, suggesting its application in cancer therapeutics (Li et al., 2021).
1 of 1
This Item | |||
|---|---|---|---|
| assay ≥97% (HPLC) | assay ≥90% | assay ≥95% | assay 97% |
| form liquid | form liquid | form liquid | form powder |
| Quality Level 100 | Quality Level 200 | Quality Level 100 | Quality Level 200 |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. - |
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Hannah R Bridges et al.
Nature communications, 11(1), 5261-5261 (2020-10-18)
Respiratory complex I (NADH:ubiquinone oxidoreductase) captures the free energy from oxidising NADH and reducing ubiquinone to drive protons across the mitochondrial inner membrane and power oxidative phosphorylation. Recent cryo-EM analyses have produced near-complete models of the mammalian complex, but leave
Zeqi Zheng et al.
International journal of nanomedicine, 15, 4501-4521 (2020-07-02)
Elevation of blood homocysteine (Hcy) level (hyperhomocysteinemia) is a risk factor for cardiovascular disorders and is closely associated with endothelial dysfunction. The present study aims to investigate the protective effect and underlying mechanism of nanoscale selenium (Nano-Se) in Hcy-mediated vascular
Samuel S W Szeto et al.
The Journal of biological chemistry, 287(27), 22509-22520 (2012-05-11)
Succinate dehydrogenase (SDH), also known as complex II, is required for respiratory growth; it couples the oxidation of succinate to the reduction of ubiquinone. The enzyme is composed of two domains. A membrane-extrinsic catalytic domain composed of the Sdh1p and
Global Trade Item Number
| SKU | GTIN |
|---|---|
| D7911-10MG | 04061833588994 |
| D7911-100MG | 04061833588987 |
| D7911-25MG | 04061833589007 |